KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Thermo Fisher Scientific (TMO) over the last 17 years, with Q3 2025 value amounting to $3.5 billion.

  • Thermo Fisher Scientific's Cash & Current Investments fell 4663.66% to $3.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 billion, marking a year-over-year decrease of 4663.66%. This contributed to the annual value of $5.6 billion for FY2024, which is 3106.44% down from last year.
  • According to the latest figures from Q3 2025, Thermo Fisher Scientific's Cash & Current Investments is $3.5 billion, which was down 4663.66% from $6.4 billion recorded in Q2 2025.
  • In the past 5 years, Thermo Fisher Scientific's Cash & Current Investments ranged from a high of $12.0 billion in Q4 2021 and a low of $1.9 billion during Q3 2022
  • For the 5-year period, Thermo Fisher Scientific's Cash & Current Investments averaged around $5.8 billion, with its median value being $5.9 billion (2025).
  • Its Cash & Current Investments has fluctuated over the past 5 years, first crashed by 7572.96% in 2022, then skyrocketed by 18161.51% in 2024.
  • Quarter analysis of 5 years shows Thermo Fisher Scientific's Cash & Current Investments stood at $4.5 billion in 2021, then surged by 90.4% to $8.5 billion in 2022, then dropped by 5.21% to $8.1 billion in 2023, then tumbled by 31.06% to $5.6 billion in 2024, then crashed by 36.34% to $3.5 billion in 2025.
  • Its Cash & Current Investments was $3.5 billion in Q3 2025, compared to $6.4 billion in Q2 2025 and $5.9 billion in Q1 2025.